» Articles » PMID: 1705245

Identification of a Surface-exposed Immunodominant Epitope on Outer Membrane Protein P1 of Haemophilus Influenzae Type B

Overview
Journal Infect Immun
Date 1991 Mar 11
PMID 1705245
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Eight murine monoclonal antibodies (MAbs) directed against outer membrane protein P1 of Haemophilus influenzae type b were generated and characterized. Seven of the eight MAbs reacted with recombinant P1 and purified P1 protein from H. influenzae type b strains MinnA and 1613; MAb P1.8 was specific for the latter strain. A panel of 32 nontypeable and 140 encapsulated Haemophilus strains recovered worldwide representing the major clonal families of serotypes a, b, and d was used to evaluate the distribution among Haemophilus strains of the epitopes identified by the P1-specific MAbs. The epitope reactive with the seven MAbs which recognized P1 from strains MinnA and 1613 was shared by 92% of the encapsulated Haemophilus isolates tested. The epitope is present in the H. influenzae type b strains from clonal families commonly recovered from cases of invasive disease in North America and Europe. A series of nested 5' and 3' deletions of the P1 gene were constructed and analyzed to localize the determinants on P1 recognized by the MAbs. MAbs P1.2, P1.4, P1.5, P1.6, and P1.7 recognized an epitope localized to the carboxy-terminal portion of P1. Murine MAbs P1.1 and P1.3 and two human MAbs, HiH-7 and HiH-10, recognized a complex epitope which was partially localized to the carboxy-terminal portion of the P1 protein. These data indicate that an immunodominant surface-exposed epitope is present on the carboxy-terminal portion of the P1 protein of type b Haemophilus isolates responsible for the majority of invasive disease in North America.

Citing Articles

Positively selected codons in immune-exposed loops of the vaccine candidate OMP-P1 of Haemophilus influenzae.

Mes T, van Putten J J Mol Evol. 2007; 64(4):411-22.

PMID: 17479342 PMC: 1915622. DOI: 10.1007/s00239-006-0021-2.


Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach.

Bolduc G, Bouchet V, Jiang R, GEISSELSODER J, Truong-Bolduc Q, Rice P Infect Immun. 2000; 68(8):4505-17.

PMID: 10899849 PMC: 98360. DOI: 10.1128/IAI.68.8.4505-4517.2000.


Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of nontypeable Haemophilus influenzae.

Kyd J, Taylor D, Cripps A Infect Immun. 1994; 62(12):5652-8.

PMID: 7960148 PMC: 303315. DOI: 10.1128/iai.62.12.5652-5658.1994.


Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies.

Panezutti H, James O, Hansen E, Choi Y, Harkness R, Klein M Infect Immun. 1993; 61(5):1867-72.

PMID: 7682997 PMC: 280777. DOI: 10.1128/iai.61.5.1867-1872.1993.


Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1.

Chong P, Yang Y, Persaud D, Haer M, Tripet B, Tam E Infect Immun. 1995; 63(10):3751-8.

PMID: 7558276 PMC: 173527. DOI: 10.1128/iai.63.10.3751-3758.1995.


References
1.
Martin D, Larose Y, Hamel J, Lagace J, Brodeur B . Heterohybridomas secreting human monoclonal antibodies against Haemophilus influenzae type b. Eur J Immunol. 1988; 18(4):601-6. DOI: 10.1002/eji.1830180417. View

2.
Munson Jr R, Hunt A . Isolation and characterization of a mutant of Haemophilus influenzae type b deficient in outer membrane protein P1. Infect Immun. 1989; 57(3):1002-4. PMC: 313214. DOI: 10.1128/iai.57.3.1002-1004.1989. View

3.
Loeb M . Protection of infant rats from Haemophilus influenzae type b infection by antiserum to purified outer membrane protein a. Infect Immun. 1987; 55(11):2612-8. PMC: 259950. DOI: 10.1128/iai.55.11.2612-2618.1987. View

4.
Granoff D, Munson Jr R . Prospects for prevention of Haemophilus influenzae type b disease by immunization. J Infect Dis. 1986; 153(3):448-61. DOI: 10.1093/infdis/153.3.448. View

5.
Brodeur B, Larose Y, Tsang P, Hamel J, Ashton F, Ryan A . Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infect Immun. 1985; 50(2):510-6. PMC: 261984. DOI: 10.1128/iai.50.2.510-516.1985. View